MPSYF Projected Dividend Yield
Ord/MorphoSys AG ( OTCBB : MPSYF )MorphoSys is engaged in the development commercialization of antibodies for therapeutic applications. Co. develops drugs using its own research and development, as well as in cooperation with pharmaceutical and biotechnology partners. Co.'s operating segments include Proprietary Development and Partnered Discovery. In the Proprietary Development segment, it develops therapeutic antibodies and peptides in the area of inflammatory disease and oncology. In the Partnered Discovery segment, the Company applies technologies for the research, development and optimization of therapeutic antibodies as drug candidates. Co. develops new treatments for patients suffering from serious diseases. 20 YEAR PERFORMANCE RESULTS |
MPSYF Dividend History Detail MPSYF Dividend News MPSYF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |